Skip to main content
SpringerLink
Log in

The biology of meningiomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Meningiomas, long neglected as a subject for biological studies, are now being examined more widely as their potential for clinical recurrence and malignancy has been recognized. Most laboratory studies have focused on descriptive analyses of the content of various molecules in ex vivo specimens removed at surgery. Perturbative experiments using cultured cells are possible, but they are complicated by senescence of the cells. The respective importance of the sex steroids (estrogen, progesterone, and androgens), classical growth factors, angiogenic factors, and proteolytic enzymes in the biological behavior of meningiomas is now apparent and is coming under more detailed scrutiny. As general theories of neoplasia crystallize in other systems, the ability of meningiomas to proliferate, invade, and provoke neovascularization will be better understood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bland JOW Russell DS: Histological types of meningiomata and a comparison of their behaviour in tissue culture with that of certain normal human tissues. J Pathol Bacteriol 47: 291–309, 1938

    Google Scholar 

  2. Korsgaard R, Clausen OP, Thorud E: Establishment of a human meningeal cell line in culture. Anticancer Res 4: 83–90, 1984

    Google Scholar 

  3. Tanaka K, Sato C, Maeda Y, Koike M, Matsutani M, Yamada K, Miyaki M: Establishment of a human malignant meningioma cell line with amplified c-myc oncogene. Cancer 64: 2243–2249, 1989

    Google Scholar 

  4. Lee WH: Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27: 389–396, 1990

    Google Scholar 

  5. Kepes JJ: Meningiomas: Biology, Pathology, and Differential Diagnosis. Masson, New York, 1982, pp 10–11

    Google Scholar 

  6. Medkhour A, Van Roey M, Sobel RA, Fingert HJ, Martuza RL: Implantation of human meningiomas into the sub-renal capsule of the nude mouse: a model for studies of tumor growth. J Neurosurg 71: 545–550, 1989

    Google Scholar 

  7. Bickerstaff ER, Small JM, Guest IA: The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 21: 89–91, 1958

    Google Scholar 

  8. Rubinstein AB, Schein M, Reichenthal E: The association of carcinoma of the breast with meningioma. Surg Gynecol Obstet 169: 334–336, 1989

    Google Scholar 

  9. Donnell MS, Meyer GA, Donegan WL: Estrogen receptor protein in intracranial meningiomas. J Neurosurg 50: 499–502, 1979

    Google Scholar 

  10. Martuza RL, MacLaughlin DT, Ojemann RG: Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. Neurosurgery 9: 665–671, 1981

    Google Scholar 

  11. Martuza RL, Miller DC, MacLaughlin DT: Estrogen and progesterone binding by cytosolic and nuclear fractions of human meningioma. J Neurosurg 62: 750–756, 1985

    Google Scholar 

  12. Tilzer LL, Plapp FV, Evans JP, Stone D, Alward K: Steroid receptor proteins in human meningiomas. Cancer 49: 633–636, 1982

    Google Scholar 

  13. Lee L-S, Chi C-W, Chang T-J, Chou M-D, Liu H-C, Liu T-Y: Steroid hormone receptors in meningiomas of Chinese patients. Neurosurgery 25: 541–545, 1989

    Google Scholar 

  14. Markwalder TM, Markwalder RV, Zava DT: Estrogen and progestin receptors in meningiomas: clinicopathologic correlations. Clin Neuropharmacol 7: 366–374, 1984

    Google Scholar 

  15. Poisson M, Pertuiset BF, Hauw JJ, Philippon J, Buge A, Moguilewsky M, Philibert D: Steroid hormone receptors in human meningiomas, gliomas, and brain metastases. J Neurooncol 1: 179–189, 1983

    Google Scholar 

  16. Blankenstein MA, van der Meulen Dijk C, Thijssen JHH: Assay of oestrogen and progestin receptors in human meningioma cytosols using immunological methods. Clin Chim Acta 165: 189–195, 1987

    Google Scholar 

  17. Piantelli M, Rinelli A, Macri E, Maggiano N, Larocca LM, Sceratti M, Roselli R, Iacoangeli M, Scambia G, Capelli A: Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer 71: 193–198, 1993

    Google Scholar 

  18. Jay JR, MacLaughlin DT, Riley KR, Martuza RL: Modulation of cell growth by sex steroid hormones in vitro. J Neurosurg 62: 757–762, 1985

    Google Scholar 

  19. Olson JJ, Beck DW, Schlechte J, Loh PM: Hormonal manipulation of meningiomas in vitro. J Neurosurg 65: 99–107, 1986

    Google Scholar 

  20. Zava DT Markwalder TM, Markwalder RV: Biological expression of steroid hormone receptors in primary meningioma cells in monolayer culture. Clin Neuropharmacol 7: 382–388, 1984

    Google Scholar 

  21. Schrell UMH, Adams EF, Fallbusch R, Greb R, Jirikowski G, Prior R, Ramalho-Ortigao FJ: Hormone dependency of cerebral meningiomas. Part I: female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73: 743–749, 1990

    Google Scholar 

  22. Moguilewsky M, Pertuiset BF, Verzat C, Philibert D, Philippon J, Poisson M: Cytosolic and nuclear sex steroid receptors in meningiomas. Clin Neuropharmacol 7: 375–381, 1984

    Google Scholar 

  23. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H: Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33: 212–217, 1993

    Google Scholar 

  24. Perrot-Applanat M, Groyer-Picard MT Kujas M: Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir 115: 20–30, 1993

    Google Scholar 

  25. Schwartz MR, Randolph RL, Cech DA, Rose JE, Panko WB: Steroid hormone binding macromolecules in meningiomas: failure to meet criteria of specific receptors. Cancer 53: 922–927, 1984

    Google Scholar 

  26. Adams EF, Schrell UMH, Fahlbusch R, Thierauf P: Hormonal dependency of cerebral meningiomas. Part 2. In vitro effect of steroids, bromocriptine, and epidermal growth factor on growth of meningiomas. J Neurosurg 73: 750–755, 1990

    Google Scholar 

  27. Maiuri F, Montagnani S, Gallicchio B, Caradente M, Lanza GG, D'Andrea F: Estrogen and progesterone sensitivity in cultured meningioma cells. Neurol Res 11: 9–13, 1989

    Google Scholar 

  28. Olson JJ, Beck DW, Schlechte J, Loh PM: Effect of the anti-progesterone RU-38486 on meningiomas implanted in nude mice. J Neurosurg 66: 584–587, 1987

    Google Scholar 

  29. Blankenstein MA, van 't Verlaat JW Croughs RJM: Hormone dependency of meningiomas (letter). Lancet 1: 1381, 1989

    Google Scholar 

  30. Olson JJ, Beck DW, MacIndoe JW, Min-Loh P: Androgen receptors in meningiomas. Cancer 61: 952–955, 1988

    Google Scholar 

  31. Maxwell M, Galanopoulos T Neville-Golden J, Antoniades HN: Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78: 456–462, 1993

    Google Scholar 

  32. Carroll RS, Zhang J, Dashner K, Sar M, Wilson EM, Black PM: Androgen receptor expression in meningiomas. J Neurosurg 82: 453–460, 1995

    Google Scholar 

  33. Weisman AS, Villemure JG, Kelly PA: Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res 46: 2545–2550, 1986

    Google Scholar 

  34. Black PM, Carroll R, Glowacka D, Riley K, Dashner K: Platelet-derived growth factor expression and stimulation in human meningiomas. J Neurosurg 81: 388–393, 1994

    Google Scholar 

  35. Jensen RL, Origitano TC, Lee YS, Weber M, Wuurster RD: In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36: 365–374, 1995

    Google Scholar 

  36. Harsh GR, Keating MT, Escobedo JA, Williams LT: Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neuro-Oncol 8: 1–12, 1990

    Google Scholar 

  37. Detta A, Kenny BG, Smith C, Logan A, Hitchcock E: Correlation of proto-oncogene expression and proliferation in meningiomas. Neurosurgery 33: 1065–1074, 1993

    Google Scholar 

  38. Sanson M, Richard S, Delattre O, Poliwka M, Mikol J, Philippon J, Thomas G: Allelic loss on chromosome 22 correlates with histopathological predictors of recurrence of meningiomas. Int J Cancer 50: 391–394, 1992

    Google Scholar 

  39. Glick RP, Unterman TG, Woude MV, Blaydes LZ: Insulin and insulin-like growth factors in central nervous system tumors. Part V: Production of insulin-like growth factors I and II in vitro. J Neurosurg 77: 445–450, 1992

    Google Scholar 

  40. Tsutsumi K, Kitagawa N, Niwa M, Himeno A, Taniyama K, Shibata S: Effect of suramin on 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells. J Neurosurg 80: 502–509, 1994

    Google Scholar 

  41. Johnson MD, Federspiel CF, Gold LI, Moses HL: Transforming growth factor-b and transforming growth factor-b receptor expression in human meningioma cells. Am J Pathol 141: 633–642, 1992

    Google Scholar 

  42. Nitta T, Sato K, Okumura K: Transforming growth factor (TGF)-b like activity of intracranial meningioma and its effect on cell growth. J Neurol Sci 101: 19–23, 1991

    Google Scholar 

  43. Koper JW, Markstein R, Kohler C, Kwekkeboom DJ, Avezaat CJ, Lamberts SW, Reubi JC: Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 74: 543–547, 1992

    Google Scholar 

  44. Reubi JC, Maurer R, Klijn JLM: High incidence of somatostatin receptors in human meningiomas and biochemnical characteristics. J Clin Endocrinol Metab 63: 433–438, 1986

    Google Scholar 

  45. Schrell UMH, Nomikos P, Fahlbusch R: Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue. J Neurosurg 77: 288–294, 1992

    Google Scholar 

  46. Jiminez-Hakim E, El-Azouzi M, Black PMcL: The effect of prolactin and bombesin on the growth of meningioma-derived cells in monolayer culture. J Neuro-Oncol 16: 185–190, 1993

    Google Scholar 

  47. Koper JW Zwarthoff EC, Hagemeijer A, Braakman R, Avezaat CJ, Berstrom M, Lamberts SW: Inhibition of the growth of cultured human meningioma cells by recombinant interferon-a. Eur J Cancer 27: 416–419, 1991

    Google Scholar 

  48. Kohn EC, Liotta LA: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856–1862, 1995

    Google Scholar 

  49. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R: Elevated levels of MR 92,000 type IV collagenase in human brain tumors. Cancer Res 53: 2208–2211, 1993

    Google Scholar 

  50. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, Okada Y: Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69–77, 1994

    Google Scholar 

  51. Weindel K, Moringlane JR, Marm D, Weich HA: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis. Neurosurgery 35: 439–449, 1994

    Google Scholar 

  52. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55: 1189–1193, 1995

    Google Scholar 

  53. Dumanski JP, Rouleau GA, Nordenskjold M, Collins VP: Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50: 5863–5867, 1990

    Google Scholar 

  54. Sanson M, Richard S, Delatre O: Allelic loss on chromosome 22 correlates with histopathologic predicators of recurrence of meningiomas. Int J Cancer 50: 391–394, 1992

    Google Scholar 

  55. Vagner-Capodano AM, Grisoli F, Gambarelli D: Correlation between cytogenetic and histopathologic findings in 75 human meningiomas. Neurosurgery 32: 892–900, 1993

    Google Scholar 

  56. Maxwell M, Galanopoulos T, Hedley-White ET, Black PM, Antoniades HN: Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer 46: 16–21, 1990

    Google Scholar 

  57. Carstens C, Meese E, Zang KD, Blin N: Human K-ras oncogene expression in meningiomas. Cancer Lett 43: 37–41, 1988

    Google Scholar 

  58. Diedrich U, Eckermann O, Schmidtke J: Rare Ha-ras and c-mos alleles in patients with intracranial tumors. Neurology 38: 587–589, 1988

    Google Scholar 

  59. Kazumoto T, Tamura M, Hoshimo H, Yuasa Y: Enhanced expression of the sis and c-myc oncogenes in human meningiomas. J Neurosurg 72: 786–791, 1990

    Google Scholar 

  60. Riva R, Larizza L: Expression of c-sis and c-fos genes in human meningiomas and neurinomas. Int J Cancer 51: 873–877, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

    Ian E. McCutcheon

Authors
  1. Ian E. McCutcheon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCutcheon, I.E. The biology of meningiomas. J Neuro-Oncol 29, 207–216 (1996). https://doi.org/10.1007/BF00165650

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165650

Key words

Search

Navigation